Impaired folic acid absorption in inflammatory bowel disease: effects of salicylazosulfapyridine (Azulfidine).
D000293:Adolescent; D000328:Adult; D000818:Animals; D001681:Biological Assay; D003093:Colitis, Ulcerative / Q000150:complications* / Q000188:drug therapy / Q000473:pathology; D003424:Crohn Disease / Q000150:complications* / Q000188:drug therapy / Q000473:pathology; D003864:Depression, Chemical; D005260:Female; D005492:Folic Acid / Q000097:blood / Q000378:metabolism; D005494:Folic Acid Deficiency / Q000209:etiology*; D006801:Humans; D066298:In Vitro Techniques; D007408:Intestinal Absorption / Q000187:drug effects*; D007583:Jejunum / Q000473:pathology; D008297:Male; D008875:Middle Aged; D051381:Rats; D012460:Sulfasalazine / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use; D014316:Tritium
D014316:Tritium; D012460:Sulfasalazine; D005492:Folic Acid